Monitoring of Hypnosis State During General Anesthesia With Propofol by Patient State Index From SEDLine®
NCT ID: NCT02706665
Last Updated: 2019-10-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
12 participants
OBSERVATIONAL
2015-12-31
2018-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Breath Monitoring of Propofol (Observational Study)
NCT01892683
Population Pharmacodynamic Modeling of the Sedative and Side Effects of Propofol
NCT02173340
Effect of Ciprofol Infusion for Induction and Maintenance on Hemodynamics and Postoperative Recovery
NCT05664386
Evaluation of Influencing Variables in Awakening Concentration and Concentration at Body Movements of Propofol TCI (Targeted Controlled Infusion) Targeted at the Effector Site
NCT04129112
Comparison of Depth of Sedation Performance Between SedLine and Comparator Device During General Anesthesia
NCT03865316
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
There is a large intra-and interindividual variability in the effect of propofol. To deal with this problem, a real-time monitoring and therefore a more accurate titration of anesthetic agents is proposed. Brain function monitors based on a processed analysis of EEG (Electroencephalogram) can help to control pharmacodynamic effects of hypnotic agents. PSI values provide a measurement of the hypnotic effect of propofol. It will be observed an inverse correlation between the propofol infusion rate and the PSI value.
Objectives:
To design a computer program to record simultaneously the propofol infusion rate, PSI and Electromyogram (EMG).
To study the correlation between PSI values obtained from the SEDLine® monitor and the infusion rate of propofol during general anesthesia.
To obtain a mathematical model of the system from data recorded with different identification techniques.
Methods:
A group of patients scheduled for surgery under a standard total intravenous anesthesia (TIVA) with propofol and remifentanil will be recruited. The hypnotic effect of propofol will be monitored with the PSI from a SEDline monitor continuously. All anesthetic doses and their changes fall within conventional dosing.
The procedure for recording data and obtaining the pharmacokinetics/pharmacodynamics (PK / PD) model will be connecting a SEDLine® monitor to a laptop with an original program developed by members of our team. The program automatically stores the infusion rate of propofol (mg/kg/h) and the simultaneous values of PSI and frontal EMG. Graphics and data collected will be explored with various systems of techniques for pattern recognition in order to get the best fit to define a mathematical model of the dose of propofol and PSI values. A subsequent computer analysis with MATLAB® will estimate the correlation between the infusion of propofol infusion rate and PSI values.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SEDline monitor
The SEDline monitor gives us the Patient State Index (PSI), a dimensionless number within a range of 0 to100.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient signed an informed consent
Exclusion Criteria
* Patients who are receiving drug therapy that may alter processed EEG monitoring and decrease the PSI accuracy.
* American Society of Anesthesiologists classification IV or higher
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Masimo Corporation
INDUSTRY
Hospital Universitario de Canarias
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jose Antonio Reboso Morales, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Hospital Universitario de Canarias
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Universitario de Canarias
San Cristóbal de La Laguna, Santa Cruz De Tenerife, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013_10
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.